Overview
- 11 inspections across 11 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2025-03-11.
At a glance
Inspections
11
Sites
11
Observations
1
Career since
Jun 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai Henlius Biologics Co., Ltd. | 11 Mar 2025 | Human Drugs | On file |
| Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 26 Jan 2024 | Human Drugs | On file |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) | 16 Jan 2024 | Human Drugs | On file |
| Cleveland Cord Blood Center | 11 Dec 2015 | Biologics | On file |
| Ipsen BioPharm Ltd | 6 May 2014 | Biologics | On file |
Sites inspected
Shanghai Henlius Biologics Co., Ltd.Shanghai, China1 insp.
Hainan Shuangcheng Pharmaceuticals Co., Ltd.Haikou, China1 insp.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)Lianyungang, China1 insp.
Cleveland Cord Blood CenterWarrensville Heights, United States1 insp.
Ipsen BioPharm LtdWrexham, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Arsen Karapetyan2 shared
Liqun Zhao1 shared
Bo Chi1 shared
Chad R Burger1 shared
Michele L Forster1 shared
Jie He1 shared
Jeremy L Wally1 shared
Rebecca K Olin1 shared
Gang Wang1 shared
Joseph D Doleski1 shared
Full investigator report
Get the verbatim findings behind Qiao Y Bobo's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site